LPA induces a pro-metastatic transcriptional signature in ovarian cancer cells that enables the prediction of poor clinical outcomes [25], suggesting a higher metastatic potential in ATX-expressing tumours. The gene discussed is ENPP2; the disease is ovarian cancer.